Anthropic Takes Legal Action Against US Defense Department Over National Security Blacklisting DXP DXPE Stock Analysis Climbs 469 Eyes on 16078 20260514 Babcock International Shares Whipsaw on Swedens Frigate Contract Award to French Rival Greenidge GREEL Stock Jumps 350 Approaching 2173 20260518 Bitcoin Slips to 74500 Faces Potential Weekly Decline Amid Geopolitical Tensions Silver Consolidation Pattern Suggests Potential Breakout as Market Watchers Eye Key Price Level Shein Acquires Everlane Fast Fashion Giant Takes Over Ethical Luxury Brand Mehul Kothari of Anand Rathi Highlights Three Banking Stocks Under 200 for ShortTerm Consideration Plus500 Anticipates Meeting Market Expectations Following 11 Revenue Growth Accenture Invests in AIPowered Cybersecurity Platform XBOW Nexa Resources Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction TBCH Q1 2026 Earnings EPS Misses Estimates Sharply Yet Stock Surges Over 11 OSRH Q4 2025 Earnings EPS Misses Estimates by 5686 Shares Decline Vertiv Holdings Q1 2026 Earnings EPS Surges Past Estimates Stock Eases Slightly MYSZ Q4 2025 Earnings EPS Misses Estimates No Revenue Reported Sharps Technology Inc STSS Q3 2025 Earnings EPS Misses Wide as PreRevenue Focus Intensifies Mercury General MCY Holds Steady Near 102 After Modest Advance Walmart WMT Slips 088 as Retail Giant Fights at Support FST Corp KBSX Slips 22 as Support at 128 Comes Into Focus Global Ship Lease GSL Drops 57 Testing Key Support Levels After Steep Decline Reliance Global Group Inc EZRA Dips 251 Testing Key Support at 369 Scotiabank Flags Lower Rent Growth Expectations for MidAmerica Apartment Communities MAA Hyperfine Inc HYPR Q1 2026 Earnings EPS Surprises to the Upside Stock Jumps 11 Genie Energy GNE Edges Higher Amid Sector Resilience Support and Resistance Levels in Focus WGS Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges Edesa Biotech Inc EDSA Q1 2026 Earnings Wider Than Expected Loss as Clinical Pipeline Progresses AFB Q3 2024 Earnings Net Investment Income per Share Reported at 011 No Analyst Estimate Available Molecular Partners Q4 2025 Earnings EPS Beat Drives Shares Higher Amid Clinical Progress PSEC Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Falls Short ADPT Q1 2026 Earnings EPS Beat Driven by Cost Discipline and Operational Progress Vaxcyte PCVX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline